(1)
Mashayekhi, P.; Noruzinia, M.; Khodaverdi, S. Metformin As a Potential Agent for Modulating the Faulty Endometriotic Mesenchymal Stem Cells: A Case-Control Study. IJRM 2022, 20, 861–872.